Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000712299 | SCV000842763 | uncertain significance | not provided | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001214251 | SCV001385924 | uncertain significance | Neuronal ceroid lipofuscinosis 7 | 2022-01-21 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). ClinVar contains an entry for this variant (Variation ID: 586145). This variant has not been reported in the literature in individuals affected with MFSD8-related conditions. This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 468 of the MFSD8 protein (p.Gly468Glu). |